Format

Send to

Choose Destination
J Thorac Oncol. 2019 Jun;14(6):e125-e126. doi: 10.1016/j.jtho.2019.01.027.

Nkx2-4 Mutation Confers Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Sarcomatoid Carcinoma.

Author information

1
Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
2
Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, Ontario, Canada.
3
Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address: yxia@zju.edu.cn.
PMID:
31122564
DOI:
10.1016/j.jtho.2019.01.027

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center